Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Siddharth Bhamre of Angel Broking, one may prefer Idea Cellular over Bharti Airtel.
According to Vishal Malkan of malkansview.com, one may see upside in Biocon.
Mithil Pradhan of Violet Arc Global Managers has a bullish stance on pharma space.
Manas Jaiswal of manasjaiswal.com recommends buying Biocon and advises selling PNB.
Vishal Malkan of malkansview.com is of the view that one may exit Biocon.
Manish Hathiramani of Deen Dayal Investments recommends buying Biocon, Suzlon Energy and Hexaware Technologies.
Chandan Taparia of Anand Rathi Securities is of the view that Biocon may head to higher levels.
Amit Harchekar of A Plus Analytics recommends selling Biocon on rally.
According to Siddharth Bhamre of Angel Broking, one may go long in Biocon with a target of Rs 464.
Sudarshan Sukhani of s2analytics.com is of the view that Apollo Tyres is an opportunity.
Sudarshan Sukhani of s2analytics.com recommends buying Tata Consultancy Services, Hindustan Unilever and Biocon.
Rahul Mohindar of viratechindia.com is of the view that one can buy Biocon with a target of Rs 485-490.
Siddarth Bhamre of Angel Broking recommends going long in Biocon at current level with a target of Rs 452.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Biocon and advises holding the stock as it may head higher.
Here are top 10 stocks to keep an eye on January 23 - ICICI Bank, Axis Bank, Cairn India, Prestige Estates, Biocon, Ipca Labs, Polaris, Phillips Carbon, Mahindra Holidays and HCL Infosystems.
Sudarshan Sukhani of s2analytics.com recommends selling Biocon.
Manish Hathiramani of Deen Dayal Investments advises selling Biocon with a target of Rs 400.
Here are top 10 stocks to watch on December 26 - Coal India, Axis Bank, Spicejet, CNX PSU Bank Index, Reliance Capital, MTNL, Biocon, Bharti Airtel, Power Grid and Ruchi Soya.
According to Kunal Bothra of LKP Securities, Biocon may touch Rs 484.
Gaurav Bissa, Derivatives Analyst at LKP Securities feels that Biocon may test Rs 490.
Amit Gupta of ICICIdirect is of the view that Biocon may move towards Rs 500-520.
Meghna V Malkan of malkansview.com recommends shorting YES Bank for a target price of Rs 655 and advises buying Jubilant Foodworks for a target price of Rs 1475.
Vishal B Malkan of malkansview.com advises selling DLF with a target of Rs 127-130 and YES Bank with a target of Rs 645-660.
Chandan Taparia of Anand Rathi Securities is of the view that Biocon may test Rs 480 and Exide Industries may touch Rs 150.
Paras Bothra of Ashika Stock Broking recommends buying Arvind for a target price of Rs 320 and Hexaware Technologies for a target price of Rs 250.